MLM
45
-5
BEN
50
9
ISRG
71
-5
EIX
70
3
RSG
65
-3
HST
39
-3
ALL
50
2
R
70
-3
SYY
49
9
MCO
71
-7
FE
44
5
XYL
35
-2
FFIV
66
-4
DD
53
-6
AN
50
-5
JNPR
50
-6
WM
74
-5
MO
60
-2
SHW
62
-6
TXT
53
-3
MLM
45
-5
BEN
50
9
ISRG
71
-5
EIX
70
3
RSG
65
-3
HST
39
-3
ALL
50
2
R
70
-3
SYY
49
9
MCO
71
-7
FE
44
5
XYL
35
-2
FFIV
66
-4
DD
53
-6
AN
50
-5
JNPR
50
-6
WM
74
-5
MO
60
-2
SHW
62
-6
TXT
53
-3
Financhill
Back

Doubleline Opportunistic Credit Fund Vs. Neurogene Industry Stock Comparison

Sell
41

DBL
Doubleline Opportunistic Credit Fund

Last Price:
15.26
Seasonality Move:
1.61%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
41
Doubleline Opportunistic Credit Fund (DBL) is a Sell

Is Doubleline Opportunistic Credit Fund a Buy, Sell or Hold?

  • The current Doubleline Opportunistic Credit Fund [DBL] share price is $15.26. The Score for DBL is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • DBL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

DBL Stock Price Chart

What is Doubleline Opportunistic Credit Fund's stock price today?

  • The Doubleline Opportunistic Credit Fund share price today is $15.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DBL is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

DBL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 38.25 Sell
Chaikin Money Flow: -35893 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.28 - 15.54) Sell
Bollinger Bands (100): (15.42 - 15.88) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

DBL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.45 Sell
20-day SMA: 15.37 Sell
50-day SMA: 15.65 Sell
200-day SMA: 15.38 Sell
8-day EMA: 15.39 Sell
20-day EMA: 15.44 Sell
50-day EMA: 15.54 Sell
200-day EMA: 15.4 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

Doubleline Opportunistic Credit Fund Earnings Growth & DBL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Doubleline Opportunistic Credit Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):